BE854268A - Pyrrolidones, leur procede de preparation et leur application therapeutique - Google Patents

Pyrrolidones, leur procede de preparation et leur application therapeutique

Info

Publication number
BE854268A
BE854268A BE177278A BE177278A BE854268A BE 854268 A BE854268 A BE 854268A BE 177278 A BE177278 A BE 177278A BE 177278 A BE177278 A BE 177278A BE 854268 A BE854268 A BE 854268A
Authority
BE
Belgium
Prior art keywords
pyrrolidons
preparation process
therapeutic application
therapeutic
application
Prior art date
Application number
BE177278A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BE854268A publication Critical patent/BE854268A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
BE177278A 1976-05-04 1977-05-04 Pyrrolidones, leur procede de preparation et leur application therapeutique BE854268A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762619638 DE2619638A1 (de) 1976-05-04 1976-05-04 Pyrrolidone und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
BE854268A true BE854268A (fr) 1977-11-04

Family

ID=5977020

Family Applications (1)

Application Number Title Priority Date Filing Date
BE177278A BE854268A (fr) 1976-05-04 1977-05-04 Pyrrolidones, leur procede de preparation et leur application therapeutique

Country Status (9)

Country Link
JP (1) JPS52133975A (fr)
BE (1) BE854268A (fr)
DE (1) DE2619638A1 (fr)
DK (1) DK194377A (fr)
ES (1) ES458264A1 (fr)
FR (1) FR2372806A1 (fr)
GB (1) GB1583163A (fr)
IT (1) IT1086223B (fr)
NL (1) NL7704739A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320136A (en) 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
WO2003074483A1 (fr) 2002-03-05 2003-09-12 Ono Pharmaceutical Co., Ltd. Composes derives de 8 azaprostaglandine et medicaments contenant ceux-ci comme principe actif

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321201A (en) 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
WO1989010359A1 (fr) * 1988-04-22 1989-11-02 2 Moskovsky Gosudarstvenny Meditsinsky Institut Im Ethers de carbalkoxymethyl d'acide acetique de lactame-1 et procede pour leur obtention
PL356662A1 (en) * 1999-12-22 2004-06-28 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
AU2001290250A1 (en) * 2000-09-21 2002-04-02 Ono Pharmaceutical Co. Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
NZ525164A (en) 2000-11-27 2005-04-29 Pfizer Prod Inc EP4 receptor selective agonists in the treatment of osteoporosis
ES2254726T3 (es) * 2001-07-16 2006-06-16 F. Hoffmann-La Roche Ag Analogos de prostaglandina como agonistas receptores de ep4.
EP1408961B1 (fr) 2001-07-16 2007-07-11 F. Hoffmann-La Roche Ag Derives de pyrrolidone comme antagonistes de prostanoide
CN101921220B (zh) 2001-07-23 2013-05-22 小野药品工业株式会社 治疗与骨质损失有关的疾病的含有ep4激动剂作为活性成分的药物组合物
CA2483555A1 (fr) * 2002-06-10 2003-12-18 Applied Research Systems Ars Holding N.V. Gamma lactames utilises en tant qu'agonistes de la prostaglandine et leur utilisation
BRPI0406717A (pt) 2003-01-10 2005-12-20 Hoffmann La Roche Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção
WO2004065365A1 (fr) * 2003-01-21 2004-08-05 Ono Pharmaceutical Co., Ltd. Derives de 8-azaprostalangine et utilisations de ces derives en tant que medicaments
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
WO2006043655A1 (fr) * 2004-10-22 2006-04-27 Ono Pharmaceutical Co., Ltd. Préparation thérapeutique pour inhalation
HUE031885T2 (en) 2012-07-19 2017-08-28 Cayman Chemical Co Inc Difluoro lactam preparations for EP4-mediated osteo-related diseases and conditions
WO2014144500A2 (fr) 2013-03-15 2014-09-18 Cayman Chemical Company, Inc. Procédés de synthèse d'un analogue difluorolactam
US9676712B2 (en) 2013-03-15 2017-06-13 Cayman Chemical Company, Inc. Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
ES2635635T3 (es) * 2013-03-15 2017-10-04 Cayman Chemical Company, Incorporated Compuestos de difluorolactama como agonistas selectivos del receptor EP4 para su uso en el tratamiento de enfermedades y afecciones mediadas por EP4
KR20160048054A (ko) 2013-07-19 2016-05-03 카이맨 케미칼 컴파니 인코포레이티드 골 성장의 촉진을 위한 방법, 시스템 및 조성물

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320136A (en) 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
WO2003074483A1 (fr) 2002-03-05 2003-09-12 Ono Pharmaceutical Co., Ltd. Composes derives de 8 azaprostaglandine et medicaments contenant ceux-ci comme principe actif

Also Published As

Publication number Publication date
JPS52133975A (en) 1977-11-09
NL7704739A (nl) 1977-11-08
DK194377A (da) 1977-11-05
FR2372806B1 (fr) 1980-02-29
ES458264A1 (es) 1978-07-16
IT1086223B (it) 1985-05-28
GB1583163A (en) 1981-01-21
DE2619638A1 (de) 1977-11-17
FR2372806A1 (fr) 1978-06-30

Similar Documents

Publication Publication Date Title
LU80081A1 (fr) Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
BE878723A (fr) Derives de 4-anilinoquinazoline, leur procede de preparation et leur application en therapeutique
FR2383157B1 (fr) Derives de chalcone, leur procede de preparation et leur application en therapeutique
BE867421A (fr) Derives de mevalonolactone, leur procede de preparation et leur application therapeutique
FR2393795B1 (fr) Derives de carbostyryle, leur procede de preparation et leurs applications en therapeutique
FR2340950A1 (fr) Esters du cefuroxime, leur procede de preparation et leur application en therapeutique
BE851893A (fr) Nouvelles aryl-3 oxazolidinones-2, leur procede de preparation et leur application en therapeutique
BE846452A (fr) Nouvelles pyrimidones, leur procede de preparation et leur applicationtherapeutique
BE847090A (fr) 15-steroides, et leur procede de preparation
FR2458547B2 (fr) Nouvelles n-aryle azolones, leur procede de preparation et leur application en therapeutique
BE864312A (fr) Nouveaux derives de la pyrrolidine, leur procede de preparation et leur application en therapeutique
BE865805A (fr) 1,2,3-thiadiazol-3-in-5-ylidene-urees, leur procede de preparation et leur utilisation
FR2349587A1 (fr) 1,3-dihydro-heteroarylspiro(isobenzofurannes), leur procede de preparation et leur application therapeutique
BE854812A (fr) Benzenesulfonylurees, leur procede de preparation et leur application therapeutique
LU79606A1 (fr) Derives de bisamidine,leur procede de preparation et leur application therapeutique
FR2353520A1 (fr) 1-aryloxy-2-hydroxy-3-aminopropanes, leur procede de preparation et leurs applications therapeutiques
BE866928A (fr) Benzene-sulfonyl urees, leur procede de preparation et leur application therapeutique
LU79266A1 (fr) Triazinones,leur procede de preparation et leur application en therapeutique
LU78873A1 (fr) Alkylthio-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,leur procede de preparation et application en therapeutique
FR2351098A1 (fr) Derives de l'isothiouree, leur procede de preparation et leur application therapeutique
BE860773A (fr) Beta-lactames monocycliques, leur procede de preparation et leur application en therapeutique
FR2330390A2 (fr) Nouvelles benzodioxanes-1,4, leur procede de preparation et leur application en therapeutique
BE866648A (fr) Derives de triazolothiadiazines, leur procede de preparation et leurs applications en therapeutique
FR2340951A1 (fr) Derives de cefuroxime, leur procede de preparation et leur application en therapeutique
BE864977A (fr) Derives de bis-benzimidazolyle substitues, leur procede de preparation et leur application en therapeutique